BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25373914)

  • 1. Non-viral immune electrogene therapy induces potent antitumour responses and has a curative effect in murine colon adenocarcinoma and melanoma cancer models.
    Forde PF; Hall LJ; de Kruijf M; Bourke MG; Doddy T; Sadadcharam M; Soden DM
    Gene Ther; 2015 Jan; 22(1):29-39. PubMed ID: 25373914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-programmed death-1 synergizes with granulocyte macrophage colony-stimulating factor--secreting tumor cell immunotherapy providing therapeutic benefit to mice with established tumors.
    Li B; VanRoey M; Wang C; Chen TH; Korman A; Jooss K
    Clin Cancer Res; 2009 Mar; 15(5):1623-34. PubMed ID: 19208793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.
    Choi KJ; Kim JH; Lee YS; Kim J; Suh BS; Kim H; Cho S; Sohn JH; Kim GE; Yun CO
    Gene Ther; 2006 Jul; 13(13):1010-20. PubMed ID: 16525479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor regression induced by intratumor therapy with a disabled infectious single cycle (DISC) herpes simplex virus (HSV) vector, DISC/HSV/murine granulocyte-macrophage colony-stimulating factor, correlates with antigen-specific adaptive immunity.
    Ali SA; Lynam J; McLean CS; Entwisle C; Loudon P; Rojas JM; McArdle SE; Li G; Mian S; Rees RC
    J Immunol; 2002 Apr; 168(7):3512-9. PubMed ID: 11907113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants.
    Allione A; Consalvo M; Nanni P; Lollini PL; Cavallo F; Giovarelli M; Forni M; Gulino A; Colombo MP; Dellabona P
    Cancer Res; 1994 Dec; 54(23):6022-6. PubMed ID: 7954438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes from heat-stressed tumour cells inhibit tumour growth by converting regulatory T cells to Th17 cells via IL-6.
    Guo D; Chen Y; Wang S; Yu L; Shen Y; Zhong H; Yang Y
    Immunology; 2018 May; 154(1):132-143. PubMed ID: 29197065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical characterisation of immunological changes at the tumour site after chemo-immunotherapy with doxorubicin, interleukin-2 and interferon-gamma.
    Lumsden AJ; Codde JP; Van der Meide PH; Gray BN
    Anticancer Res; 1996; 16(3A):1145-54. PubMed ID: 8702226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated antigen/IL-21-transduced dendritic cell vaccines enhance immunity and inhibit immunosuppressive cells in metastatic melanoma.
    Aravindaram K; Wang PH; Yin SY; Yang NS
    Gene Ther; 2014 May; 21(5):457-67. PubMed ID: 24572790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma.
    Stoppacciaro A; Melani C; Parenza M; Mastracchio A; Bassi C; Baroni C; Parmiani G; Colombo MP
    J Exp Med; 1993 Jul; 178(1):151-61. PubMed ID: 7686211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour cell expression of B7 costimulatory molecules and interleukin-12 or granulocyte-macrophage colony-stimulating factor induces a local antitumour response and may generate systemic protective immunity.
    Chong H; Todryk S; Hutchinson G; Hart IR; Vile RG
    Gene Ther; 1998 Feb; 5(2):223-32. PubMed ID: 9578842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor cell lysate-pulsed dendritic cells induce a T cell response against colon cancer in vitro and in vivo.
    Wu YG; Wu GZ; Wang L; Zhang YY; Li Z; Li DC
    Med Oncol; 2010 Sep; 27(3):736-42. PubMed ID: 19669608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cell-tumor coculturing vaccine can induce antitumor immunity through both NK and CTL interaction.
    Kim KD; Choi SC; Kim A; Choe YK; Choe IS; Lim JS
    Int Immunopharmacol; 2001 Nov; 1(12):2117-29. PubMed ID: 11710541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strengthening of antitumor immune memory and prevention of thymic atrophy mediated by adenovirus expressing IL-12 and GM-CSF.
    Choi KJ; Zhang SN; Choi IK; Kim JS; Yun CO
    Gene Ther; 2012 Jul; 19(7):711-23. PubMed ID: 21993173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells.
    Cao X; Zhang W; Wang J; Zhang M; Huang X; Hamada H; Chen W
    Immunology; 1999 Aug; 97(4):616-25. PubMed ID: 10457215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory response.
    Cavallo F; Martin-Fontecha A; Bellone M; Heltai S; Gatti E; Tornaghi P; Freschi M; Forni G; Dellabona P; Casorati G
    Eur J Immunol; 1995 May; 25(5):1154-62. PubMed ID: 7539748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active specific immunotherapy of pulmonary metastasis with vaccinia melanoma oncolysate prepared from granulocyte/macrophage-colony-stimulating-factor-gene-encoded vaccinia virus.
    Ju DW; Cao X; Acres B
    J Cancer Res Clin Oncol; 1996; 122(12):716-22. PubMed ID: 8954168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice.
    Kishida T; Asada H; Satoh E; Tanaka S; Shinya M; Hirai H; Iwai M; Tahara H; Imanishi J; Mazda O
    Gene Ther; 2001 Aug; 8(16):1234-40. PubMed ID: 11509956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different tumours, transduced with different cytokine genes as G-CSF and IL-2, show inhibition of tumour take through neutrophil activation but differ in T cell functions.
    Stoppacciaro A; Forni G; Colombo MP
    Folia Biol (Praha); 1994; 40(1-2):89-99. PubMed ID: 7525363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Kunjin replicon vector encoding granulocyte macrophage colony-stimulating factor for intra-tumoral gene therapy.
    Hoang-Le D; Smeenk L; Anraku I; Pijlman GP; Wang XJ; de Vrij J; Liu WJ; Le TT; Schroder WA; Khromykh AA; Suhrbier A
    Gene Ther; 2009 Feb; 16(2):190-9. PubMed ID: 19092857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.